Halcyon Life Sciences Private Limited
About Halcyon Life Sciences Private Limited
Data last updated:
Halcyon Life Sciences Private Limited is a private limited company based in Chandigarh, India, a subsidiary of Rn Chemicals & Pharmaceutical Private Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 25 February 2008 and has been in existence for over 18 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U85190CH2008PTC031103. Its GSTIN is 04AADCK4208J1ZS (Chandigarh). The company holds 9 GST registrations, of which 3 are active.
The company has an authorised share capital of ₹47 Cr and a paid-up capital of ₹46.48 Cr. It was formerly known as Kiran Flour Mill Industries Private Limited. It is led by directors Anil Kumar Gupta and Neeraj Gupta.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Plot No 337, Workyard Industrial And Business Park Phase 2, Chandigarh, India – 160002.
As per the financials filed for FY 2025, the company reported a revenue of ₹26,000, a growth of 8% compared to the previous year. For the same year it recorded a net loss of ₹28,000 (net margin -107.7%) and EBITDA of -₹28,000 (EBITDA margin -107.7%). Revenue has declined at a compounded annual rate (CAGR) of 28% over three years and 60% over five years.
As per MCA filings, the company has satisfied charges of ₹1,341.31 Cr on record. Court records list 8 cases involving the company, including 7 filed by the company and 1 filed against it; 1 case is pending. The company has 9 deals on record (4 funding rounds, 3 secondary share transfers, 1 convertible or debt financing), with disclosed funding of ₹51.54 Cr; the latest was in March 2021. Its 10 peer companies in the Pharma industry (Pharma Retail and Distribution) are compared by revenue, 5 larger and 5 smaller; the largest is Dotcom Pharma Private Limited with revenue of ₹28,500.
The current compliance status is marked as compliant by the Registrar of Companies.
CIN History of Halcyon Life Sciences Private Limited
Halcyon Life Sciences has one previous CIN (Corporate Identification Number): U15311CH2008PTC031103. The current CIN is U85190CH2008PTC031103, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U85190CH2008PTC031103 | Current |
| U15311CH2008PTC031103 | Previous |
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressPlot No 337, Workyard Industrial And Business Park Phase 2, Chandigarh, India – 160002
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Halcyon Life Sciences Private Limited
The main business activity of Halcyon Life Sciences is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Halcyon Life Sciences Private Limited FY 2024 filings available
Halcyon Life Sciences Private Limited reported revenue of ₹26,000 (up 8% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Halcyon Life Sciences Private Limited
Revenue rose 8% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 60%. EBITDA fell 103% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Halcyon Life Sciences Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹28,000 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹28,000 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Halcyon Life Sciences Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -107.7% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -107.7% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Halcyon Life Sciences are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Halcyon Life Sciences Private Limited
Halcyon Life Sciences has 2 current directors and 9 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anil Kumar Gupta Also directs: Ang Capital Investments Private Limited | Director | 30 Mar 2023 | 3 Years 6 Months | Current |
| Neeraj Gupta Also directs: Lente Waters Private Limited, Ang Healthcare India Private Limited, Recorders & Medicare Systems Private Limited and 1 more | Director | 30 Mar 2023 | 3 Years 6 Months | Current |
Peer Comparison of Halcyon Life Sciences Private Limited
Halcyon Life Sciences Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Dotcom Pharma Private Limited | ₹28,500 (FY 2024) | •••• | •••• | -94.0% | •••• | Noida, Uttar Pradesh, India |
| Adijan Pharmaceuticals Private Limited | ₹26,827 (FY 2019) | •••• | •••• | -97.0% | •••• | Ranchi, Jharkhand, India |
| Violio Healthcare Limited | ₹26,300 (FY 2025) | •••• | •••• | 39.0% | •••• | Ahmedabad, Gujarat, India |
| Embark Life Science Private Limited | ₹26,289 (FY 2025) | •••• | •••• | -87.0% | •••• | Vadodara, Gujarat, India |
| Rachamim Private Limited | ₹26,029 (FY 2024) | •••• | •••• | •••• | Sagar, Madhya Pradesh, India | |
| Halcyon Life Sciences Private Limited this company | ₹26,000 (FY 2025) | •••• | •••• | 8.0% | •••• | Chandigarh, India |
| Raj Medicure Private Limited | ₹25,830 (FY 2025) | •••• | •••• | •••• | Howrah, West Bengal, India | |
| K.S.S. Servcor Private Limited | ₹25,682 (FY 2023) | •••• | •••• | -99.0% | •••• | Lucknow, Uttar Pradesh, India |
| Jamrex Remedies Private Limited | ₹25,530 (FY 2020) | •••• | •••• | -98.0% | •••• | Saravananpatti, Tamil Nadu, India |
| Dialforhealth Greencross Limited | ₹25,000 (FY 2025) | •••• | •••• | 39.0% | •••• | Ahmedabad, Gujarat, India |
| Tirumala Surgical and Pharmaceuticals Private Limited | ₹24,710 (FY 2022) | •••• | •••• | •••• | Bhubaneswar, Odisha, India |
Peers are the five companies nearest above and the five nearest below Halcyon Life Sciences by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Halcyon Life Sciences Private Limited
Halcyon Life Sciences Private Limited is audited by Harjeet Parvesh & co. for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Harjeet Parvesh & co. | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Halcyon Life Sciences Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Halcyon Life Sciences Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 25 Apr 2014 | State Bank of India | ₹18.46 Cr | Satisfied |
| 27 Mar 2014 | State Bank of Patiala | ₹20.52 Cr | Satisfied |
| 31 Dec 2013 | State Bank of India | ₹18.46 Cr | Satisfied |
| 28 Mar 2013 | Punjab National Bank | ₹1,002.87 Cr | Satisfied |
| 21 Jan 2012 | State Bank of India | ₹105 Cr | Satisfied |
Total charge records: 8 View all charges
Deals & Funding of Halcyon Life Sciences Private Limited
Halcyon Life Sciences Private Limited has 9 deals on record (4 funding rounds, 3 secondary share transfers, 1 convertible or debt financing), with disclosed funding of ₹51.54 Cr; the latest was in March 2021.
Deals on record (5 of 9)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2021 | Funding round | ₹25 Cr | Investors: Ind Swift Laboratories Limited |
| Mar 2021 | Secondary share transfer | Undisclosed | Buyer: Ind Swift Laboratories Limited , Ind Swift Laboratories Limited & Rishav Mehta, Ind Swift Laboratories Limited & Pardeep Verma Seller: Essix Biosciences Limited , 2 individuals |
| Mar 2018 | Acquisition | Undisclosed | Buyer: Essix Biosciences Limited Seller: A.K.J. Portfolios Private Limited , SRM Portfolios Private Limited , V K M Portfolios Private Limited |
| Mar 2013 | Secondary share transfer | Undisclosed | Buyer: Zeus Trading Enterprise Pte. Ltd Seller: N R M Portfolios Private Limited |
| Jan 2013 | Funding round | ₹8 Cr | Investors: A.K.J. Portfolios Private Limited , N R M Portfolios Private Limited , V K M Portfolios Private Limited |
Full deal history
All 9 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal Cases of Halcyon Life Sciences Private Limited
Halcyon Life Sciences Private Limited has 8 court cases on record: 7 filed by Halcyon Life Sciences, 1 filed against it. 1 case is pending and 7 are disposed. Status as checked between 02 Oct 2026 and 04 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 5 | 0 | 1 |
| District courts | 3 | 1 | 0 |
Cases on record (5 of 8)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Gurugram, Haryana | Cheque dishonour complaint | Filed against the company by Bibby Financial Services (India) Private Limited | Disposed |
| District court, SAS Nagar, Punjab | Civil suit | Filed by the company against Essix Biosciences Limited | Disposed |
| High Court of Punjab and Haryana | Criminal miscellaneous application | Filed by the company against Bibby Financial Services (India) Private Limited | Disposed |
| High Court of Jammu and Kashmir and Ladakh | Writ petition | Filed by the company against Union of India Th Secretary Deptt of Revenue Ministry of Finance New Delhi | Pending |
| High Court of Punjab and Haryana | Writ petition | Filed by the company against Income Tax Officer | Disposed |
Full case history
All 8 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Halcyon Life Sciences Private Limited
Halcyon Life Sciences Private Limited has a workforce of 0 employees as of Apr 07, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Halcyon Life Sciences Private Limited
Halcyon Life Sciences Private Limited has 9 board changes on record since 2009: 2 appointments and 7 cessations. The latest: Anil Kumar Gupta ceased to be Additional Director on 29 Sep 2023.
18 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Halcyon Life Sciences Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Halcyon Life Sciences Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Halcyon Life Sciences Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Halcyon Life Sciences Private Limited
Halcyon Life Sciences has 9 GST registrations: 3 active and 6 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 04AADCK4208J1ZS | Chandigarh | Active | 01 Jul 2017 |
| 03AADCK4208J3ZS | Punjab | Active | 24 Oct 2017 |
| 01AADCK4208J3ZW | Jammu and Kashmir | Active | 15 Dec 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Halcyon Life Sciences Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Halcyon Life Sciences Private Limited
Halcyon Life Sciences is an active private limited company based in Chandigarh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 25 February 2008 (18+ years old) and is registered under CIN U85190CH2008PTC031103.
Halcyon Life Sciences reported revenue of ₹26,000 for FY 2025 (up 8% YoY).
Halcyon Life Sciences has 2 current directors:
- Anil Kumar Gupta - Director
- Neeraj Gupta - Director
Halcyon Life Sciences reported a net loss of ₹28,000 (net margin -107.7%) and EBITDA of -₹28,000 (EBITDA margin -107.7%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Halcyon Life Sciences is -28% over three years and -60% over five years. In the latest year (FY 2025) revenue rose 8%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Halcyon Life Sciences is 04AADCK4208J1ZS, registered in Chandigarh. The company has 9 GST registrations in all, of which 3 are active and 6 are cancelled or inactive. Other active GSTINs include 03AADCK4208J3ZS (Punjab), 01AADCK4208J3ZW (Jammu and Kashmir).
The CIN (Corporate Identification Number) of Halcyon Life Sciences is U85190CH2008PTC031103. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Halcyon Life Sciences has 8 court cases on record: 7 filed by the company and 1 filed against it. 1 is pending. Most are in the high courts.
Halcyon Life Sciences was incorporated on 25 February 2008, making it 18+ years old. It is registered with the Registrar of Companies, Chandigarh.
Halcyon Life Sciences has 9 deals on record (4 funding rounds, 3 secondary share transfers, 1 convertible or debt financing), with disclosed funding of ₹51.54 Cr; the latest was in March 2021.
The peers of Halcyon Life Sciences by revenue are Dotcom Pharma Private Limited, Adijan Pharmaceuticals Private Limited, Violio Healthcare Limited, Embark Life Science Private Limited, Rachamim Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).